The Platform
OrganoidOS™ — modular intelligence for organoid labs
Each module solves a distinct bottleneck in the organoid workflow. Use one or deploy the full stack — they share a unified data layer that improves with every run.
From literature to optimized protocol — in hours, not months
AI-native protocol discovery, design, and optimization. Protocol Foundry ingests 24K+ organoid papers and 800+ protocols to synthesize evidence-backed workflows tailored to your indication and cell type.
A scientific collaborator that reasons across organoid biology
Multi-agent scientific reasoning system for organoid science. Feyerabend AI coordinates specialized agents across literature, protocol, data, and simulation domains — surfacing insights your team would take weeks to find manually.
Your organoid data, unified and queryable
AI Data Lakehouse for organoid data. Conflo ingests, normalizes, and enriches experiment records, imaging data, and protocol outputs into a structured knowledge layer — ready for analytics and model training.
Simulate organoid behavior before you build it in the lab
In-silico organoid simulation engine currently in early R&D. OrganoSim will let teams predict protocol outcomes, screen conditions, and de-risk experimental decisions — before any wet-lab work begins.
A foundation model trained on organoid biology at scale
OrganoidFM is OrganoBit's organoid-specific foundation model in early R&D. Each customer engagement contributes to a compounding data moat that makes protocol quality better for every participant.
Built for CROs
Three types of organoid CRO. One platform that serves all of them.
OrganoBit's beachhead is the in-vitro CRO market across APAC — Singapore, Hong Kong, and Australia. Whether you're scaling established organoid services, expanding into new indications, or building an organoid practice from scratch, OrganoidOS™ reduces risk and accelerates time-to-first-result.
Organoid Expert CRO
Pain
Maintaining consistency at scale as competition grows
OrganoBit Solution
Protocol Foundry creates a validated, reproducible protocol library that scales with your panel. Feyerabend AI keeps your team ahead of new literature and method improvements.
Organoid Expansion CRO
Pain
Protocol drift and trial-and-error when adding new indications
OrganoBit Solution
Conflo de Organoid™ normalizes cross-model data so you can compare protocols across indications. Protocol Foundry generates evidence-backed starting points for new cell types — not educated guesses.
Organoid Adopter CRO
Pain
No in-house organoid data model; QC uncertainty; risk of disappointing early clients
OrganoBit Solution
OrganoidOS™ gives you a built-in data model, QC-aware protocol guidance, and a scientific reasoning layer — so your first organoid engagements are backed by 24K+ papers of evidence, not just internal expertise.
Why OrganoBit
Chemistry, proteins, and cells all have simulation engines. Organoids should too.
OrganoBit occupies Category III: AI-Native Organoid TechBio — distinct from generic in-silico platforms (not organoid-specific) and wet-lab/hardware-driven organoid biotech. We are building the first organoid-specific intelligence layer.
Workflow Moat
Feyerabend AI's scientific agent system creates deep integration into lab workflows. Teams that adopt it don't just use software — they depend on a collaborator that learns their preferences and history.
Data Moat
The organoid data refinery is curated, validated, and continuously enriched through cross-customer learning. Each engagement strengthens the foundation for all participants.
Protocol Engine Moat
Cross-customer protocol validation creates a compounding loop: each new client improves protocol quality for all. This is a flywheel that generic TechBio platforms cannot replicate.
Traction
Early momentum across data, IP, commercial, and community
OrganoBit is pre-revenue and pre-seed stage, with active pilots and a growing network of CRO, biopharma, and supply chain relationships. The foundation — data, IP, infrastructure, and relationships — is being built in parallel.
Commercial
- 2 pilot projects underway with CRO partners
- 20+ active conversations — CROs, biopharma, supply chain
- Beachhead markets: Singapore, Hong Kong, Australia
Knowledge Infrastructure
- 24,000+ organoid literature sources ingested
- 1,200+ patents analyzed and structured
- 800+ protocols in the knowledge base
- 8M+ academic papers accessible via integrated database
IP & Legal
- 3 trademark sets registered
- 8 IP consultation sessions completed
- WIPO-IPOS project underway
Partnerships & Community
- 30+ bio/medtech/AI events attended
- AWS Activate member
- Up to USD 100K in cloud credits (AWS + Azure)
- 7 incubator applications; 1 finalist, 1 ongoing
Pre-Seed SAFE — Q3/Q4 2026
USD 888K · $12M–$18M post-money valuation cap
Targeting family offices, deep-tech venture builders, and experienced angel investors comfortable with formation-stage entry. 12-month runway to first paid LOI.
Ready to start?
Start an organoid pilot backed by 24K+ papers of evidence
OrganoBit works with CROs and pharma teams in APAC to deploy Protocol Foundry and Feyerabend AI as a structured pilot. Two pilots are running now — join the next cohort.